NYSE$SHO
Sunstone Hotel Investors Inc · Q3 2020 earnings
Q3 2020 earnings · · Investor relations
Briefing
Sunstone's third-quarter results were impacted by the global pandemic, however, the company saw several signs that the recovery that began in May and June appeared to be gaining steam.
Sunstone Hotel Investors reported a challenging third quarter due to the ongoing global pandemic. Despite the difficulties, the company saw positive signs of recovery, with sequential monthly gains in occupancy and improved transient room reservations. The company is focused on reducing cash burn and maintaining a strong liquidity position.
- Comparable portfolio revenues were $24 million and RevPAR was $17.58, which represents a decline of 91% and 92% respectively, compared to the third quarter of last year.
- The company has successfully resumed operations at the majority of its hotels.
- Those hotels that have been open, in general, have achieved sequential monthly gains in occupancy.
- Transient room reservations have gradually improved over the past few months.
Headline financials
Revenue & EPS history
Sunstone · Revenue · Quarterly
$28.9M
Forward guidance
The company expects portfolio performance to improve in the fourth quarter and beyond now that several of their larger hotels have resumed operations. The company estimates a total monthly corporate cash burn rate before capital investment of approximately $16 to $20 million a month.
Tailwinds
- The company has successfully resumed operations at the majority of its hotels.
- Those hotels that have been open, in general, have achieved sequential monthly gains in occupancy.
- Transient room reservations have gradually improved over the past few months.
- Group production, which remains well off normal levels, increased on a sequential basis.
- The company's monthly cash burn rate has been further reduced as well as their significant liquidity position.
Headwinds
- Nearly all of the group business cancelled in the third quarter.
- Group cancellations in the first quarter of 2021 have increased.
- Group business will not return in scale until there is greater comfort in traveling and congregating.
- Group business is unlikely to return in a meaningful way until a vaccine or reliable therapeutics are developed.
- The third quarter adjusted EBITDA was a loss of $36 million
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2020
-0.0%
Avg return
Earnings day
+0.6%
Avg return
5 days after
+1.0%
Avg return
30 days after
45%
29 / 65 earnings
Positive
+20.1%
Q3 2020
Best reaction
-10.0%
Q4 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.2% | +8.0% | +18.3% | |
| Q4 2025 | -3.7% | +0.5% | -7.3% | |
| Q3 2025 | +1.8% | +2.5% | -3.8% | |
| Q1 2025 | -2.9% | +0.5% | +0.8% | |
| Q4 2024 | -5.8% | -8.2% | -13.9% | |
| Q3 2024 | -4.1% | -7.3% | +12.5% | |
| Q2 2024 | +0.0% | -1.6% | +2.4% | |
| Q1 2024 | +1.9% | +0.7% | +0.3% | |
| Q4 2023 | -0.1% | +0.6% | -1.5% | |
| Q3 2023 | -1.5% | +0.6% | +5.6% | |
| Q2 2023 | +0.0% | -0.6% | -6.0% | |
| Q1 2023 | +3.5% | +5.5% | +4.9% | |
| Q4 2022 | +7.0% | +7.4% | -11.6% | |
| Q3 2022 | -4.0% | +4.5% | -0.7% | |
| Q2 2022 | -0.5% | +0.5% | -2.4% | |
| Q1 2022 | -4.9% | -7.8% | +1.4% | |
| Q4 2021 | -10.0% | -7.6% | +0.9% | |
| Q3 2021 | +2.2% | -0.9% | -15.1% | |
| Q2 2021 | -1.2% | -0.2% | +2.7% | |
| Q1 2021 | -2.1% | -3.2% | -2.1% | |
| Q4 2020 | +6.3% | +8.8% | +15.5% | |
| Q3 2020 | +20.1% | +19.4% | +38.1% | |
| Q2 2020 | +4.1% | +10.7% | +14.7% | |
| Q1 2020 | -9.5% | -18.8% | +13.7% | |
| Q4 2019 | -1.8% | -1.9% | -46.8% | |
| Q3 2019 | +3.3% | +0.6% | -1.2% | |
| Q2 2019 | +0.7% | -0.9% | -0.5% | |
| Q1 2019 | -2.3% | -1.9% | -6.7% | |
| Q4 2018 | +2.7% | +3.1% | +3.2% | |
| Q3 2018 | +1.5% | +4.4% | +2.8% | |
| Q2 2018 | +0.7% | +1.2% | +3.3% | |
| Q1 2018 | +1.8% | +3.3% | +6.8% | |
| Q4 2017 | -0.4% | -1.6% | -5.9% | |
| Q3 2017 | -0.8% | +0.2% | +0.9% | |
| Q2 2017 | -1.1% | +0.7% | -2.9% | |
| Q1 2017 | +2.6% | +5.2% | +5.3% | |
| Q4 2016 | -0.9% | -2.8% | -2.8% | |
| Q3 2016 | -1.9% | -1.4% | +19.2% | |
| Q2 2016 | +2.1% | +0.5% | -2.4% | |
| Q1 2016 | -1.2% | — | — | |
| Q4 2015 | +1.4% | — | — | |
| Q3 2015 | +1.6% | — | — | |
| Q2 2015 | +1.8% | — | — | |
| Q1 2015 | -1.0% | — | — | |
| Q4 2014 | +0.8% | — | — | |
| Q3 2014 | -1.0% | — | — | |
| Q2 2014 | +1.8% | — | — | |
| Q1 2014 | +1.9% | — | — | |
| Q4 2013 | +2.1% | — | — | |
| Q3 2013 | +2.1% | — | — | |
| Q2 2013 | +1.0% | — | — | |
| Q1 2013 | +2.0% | — | — | |
| Q4 2012 | -2.0% | — | — | |
| Q3 2012 | -3.2% | — | — | |
| Q2 2012 | +1.6% | — | — | |
| Q1 2012 | +2.0% | — | — | |
| Q4 2009 | -1.8% | — | — | |
| Q4 2011 | -1.8% | — | — | |
| Q3 2011 | -2.9% | — | — | |
| Q3 2010 | -2.9% | — | — | |
| Q2 2011 | -3.1% | — | — | |
| Q2 2010 | -3.1% | — | — | |
| Q1 2011 | -1.5% | — | — | |
| Q1 2010 | -1.5% | — | — | |
| Q4 2010 | -1.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro